Lee Ann 4
4 · Coya Therapeutics, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Lee Ann
Director
Transactions
- Conversion
Common Stock, par value $0.0001 per share
2023-01-03$4.00/sh+6,479$25,916→ 16,479 total - Purchase
Common Stock, par value $0.0001 per share
2023-01-03+10,000→ 10,000 total - Purchase
Warrant to Purchase Common Stock
2023-01-03+5,000→ 9,479 totalExercise: $7.50From: 2023-01-03Exp: 2025-01-03→ Common Stock, par value $0.0001 per share (5,000 underlying) - Conversion
6% Convertible Note
2023-01-03→ 6,479 totalExercise: $4.00→ Common Stock, par value $0.0001 per share (6,479 underlying)
Footnotes (2)
- [F1]Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering ("IPO") at a combined purchase price $5.00 per share and accompanying warrant.
- [F2]Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum.